Submission Details
| 510(k) Number | K971725 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | May 09, 1997 |
| Decision Date | June 18, 1997 |
| Days to Decision | 40 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
K971725 is an FDA 510(k) clearance for the OPUS PROGESTERONE, a Radioimmunoassay, Progesterone (Class I — General Controls, product code JLS), submitted by Behring Diagnostics, Inc. (Westwood, US). The FDA issued a Cleared decision on June 18, 1997, 40 days after receiving the submission on May 9, 1997. This device falls under the Chemistry review panel. Regulated under 21 CFR 862.1620.
| 510(k) Number | K971725 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | May 09, 1997 |
| Decision Date | June 18, 1997 |
| Days to Decision | 40 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
| Product Code | JLS — Radioimmunoassay, Progesterone |
| Device Class | Class I — General Controls |
| CFR Regulation | 21 CFR 862.1620 |